Alamar Biosciences launches the NULISAqpcr™ Custom Assay Development Kit to advance the development of novel biomarker assays for clinical research

FREMONT, Calif., Feb. 24, 2025 /PRNewswire/ — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the release of the NULISAqpcr™ Custom Assay Development Kit, a groundbreaking product that empowers researchers to create highly sensitive and precise biomarker assays tailored to their specific research needs, expanding […] L'articolo Alamar Biosciences launches the NULISAqpcr™ Custom Assay Development Kit to advance the development of novel biomarker assays for clinical research proviene da La Ragione.

CONTINUA A LEGGERE